
Compounded Semaglutide
$99 /month · 90-Day Plan
- Once-weekly injection
- The same active ingredient as Wegovy® and Ozempic®
- Dose set and adjusted by your clinician
- Same price at every dose
One intake. A licensed clinician decides between compounded Semaglutide and Tirzepatide, sets your dose, and adjusts it as you go.


$99 /month · 90-Day Plan

$149 /month · 90-Day Plan
Complete one intake. A licensed clinician reviews it and prescribes the medication and starting dose that fit you. Already on one of these? Say so in the intake and the clinician will plan around your current dose.
| Semaglutide | Tirzepatide | |
|---|---|---|
| Class | GLP-1 receptor agonist | GIP + GLP-1 dual agonist |
| How it works | Mimics the gut hormone GLP-1: slows stomach emptying, reduces appetite | Mimics GIP and GLP-1: the same appetite effects through two hormone pathways |
| How you take it | One small injection a week | One small injection a week |
| Dosing | Starts low, raised step by step by your clinician | Starts low, raised step by step by your clinician |
| Same active ingredient as | Wegovy®, Ozempic® | Zepbound®, Mounjaro® |
| Price | $99/month | $149/month |
| Who decides | Your clinician | Your clinician |
A licensed clinician reviews your intake. If approved, you get a prescription matched to you, not a menu.
A 90-day supply of compounded Semaglutide or Tirzepatide, shipped free to your door.
A quick check-in every cycle and a full clinician follow-up every other cycle. Dose changes when they make sense, never on your own.
Have these ready for the intake: your medication, last dose and date, the concentration on the label, and how much you inject. Not sure? A clear photo of the prescription label is enough. Labs are optional; a clinician may request them based on your history.

Complete a secure medical questionnaire from home, on any device.

A licensed U.S. clinician reviews your intake and chooses the medication and starting dose. Not prescribed? Full refund.

Your 90-day supply ships free from a PCAB-accredited pharmacy to your door.

A quick check-in each cycle and a full clinician follow-up every other cycle, so your dose keeps up with you.
Intake and clinician review
Quick four-question check-in
Full follow-up with a clinician visit
The pattern repeats every 90-day cycle

Smaller portions feel like enough. The constant background hunger fades for most people within the first weeks.

Food moves through your stomach more slowly, so meals satisfy for longer and snacking loses its pull.

Many people notice less “food noise”, the looping thoughts about the next meal or a late-night snack.

Alongside weight loss, trials of the active ingredients showed improvements in blood sugar, blood pressure, and waist size.
GLP-1 medications change how hungry you feel and how quickly you feel full. That is what does most of the work. Here is what people commonly report in the first months on treatment. Individual results vary.

In STEP 1, 1,961 adults with overweight or obesity took weekly semaglutide or placebo alongside lifestyle support. The semaglutide group lost an average of 14.9% of body weight, versus 2.4% on placebo.Wilding et al., NEJM 2021

In SURMOUNT-1, 2,539 adults took weekly tirzepatide or placebo. At the highest dose, average weight loss was 20.9%, versus 3.1% on placebo. The 5 mg and 10 mg doses lost 15.0% and 19.5%.Jastreboff et al., NEJM 2022

In STEP 1, 86.4% of participants on semaglutide reached the 5% mark clinicians consider clinically meaningful, compared with 31.5% on placebo. Half lost 15% or more.Wilding et al., NEJM 2021

Alongside weight, the semaglutide group lost an average of 13.5 cm around the waist, versus 4.1 cm on placebo, with improvements in blood pressure, blood sugar, and lipids.Wilding et al., NEJM 2021
Results from the STEP 1 and SURMOUNT-1 trials of the FDA-approved brand-name products, published in NEJM in 2021 and 2022, at their target doses and with diet and activity support. Compounded medications were not studied in these trials. Individual results vary.
$99 /month

$149 /month

No. You complete one intake, and a licensed clinician chooses the medication and starting dose based on your history, your goals, and whether you're already on treatment. If you have a preference or a history with one of them, say so in the intake; the clinician will take it into account.
Both are once-weekly injections that mimic gut hormones to reduce appetite and slow stomach emptying. Semaglutide works on the GLP-1 pathway. Tirzepatide works on GLP-1 and GIP. In trials of the brand-name products, tirzepatide produced larger average weight loss at its highest dose, but the right choice depends on your history, tolerance, and what you're currently taking.
Adults 18 to 80 with a BMI typically of 25 or higher, or 20 or higher if you're already on a GLP-1. Pregnancy, breastfeeding, planning a pregnancy, a personal or family history of medullary thyroid cancer or MEN-2, pancreatitis, gastroparesis, and type 1 diabetes rule it out. The clinician makes the final decision after reviewing your full intake.
Usually, yes. Tell us in the intake what you take, your last dose and its date, the concentration on the label, and how much you inject. If you're unsure, upload a clear photo of the prescription label. If it's been a while since your last dose, the clinician may restart you lower for safety.
Not to start. Labs are optional, but a clinician may request them based on your history. If you have recent results, you can share them in the intake.
One small injection under the skin, once a week, usually in the abdomen or thigh. Your medication arrives with instructions, and your care team can answer questions before your first dose. Most people find it easier than expected.
Common: nausea, constipation, diarrhea, indigestion, and reduced appetite, mostly in the first weeks and after dose increases. Rare but serious: pancreatitis, gallbladder problems, low blood sugar, kidney problems, and allergic reactions. Report anything concerning to your care team, and call 911 in an emergency.
Appetite usually changes within the first weeks. Weight loss builds gradually as your dose is stepped up over the first few months. In trials of the brand-name products, results kept improving through the first year. Everyone responds differently, and there are no guarantees.
Semaglutide is $99 per month and Tirzepatide is $149 per month, billed as a 90-day plan with a 3-month minimum. That covers the clinician review, your prescription, the medication, free shipping, and your check-ins. No membership fees, and the price doesn't change with your dose.
You get a full refund. The clinician may explain why and suggest next steps.
Before you submit your intake, you can walk away at no cost. After the intake is submitted to a clinician, cancellation carries a $70 fee. Once your medication has shipped, it can't be returned or refunded, since it's a prescription.
No. Compounded Semaglutide and Tirzepatide are prepared by licensed, PCAB-accredited pharmacies for an individual prescription. They contain the same active ingredients as the brand-name products but are not reviewed or approved by the FDA and may differ from them.
T·TIME is cash pay and doesn't bill insurance. Some plans reimburse related costs; check with yours.
You'll get a quick check-in during each 90-day cycle and a full clinician follow-up every other cycle. Your dose can go up, hold, or come down based on how you're doing, and you can message your care team in between.

One intake. A licensed clinician chooses the medication and dose that fit you. If it's not right for you, you get a full refund.
Start your intake